Elizabeth Luis

3.5k citations

18 papers · 885 indexed · h-index 15

Molecular Biology
Oncology top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Cellular and Molecular Neuroscience top 10%
Endocrinology, Diabetes and Metabolism top 10%

Co-authors: Lino C. Gonzalez Paul Polakis Hartmut Koeppen Sarajane Ross Min Lu Avi Ashkenazi Xiaofen Ye Scot A. Marsters
Topics: Monoclonal and Polyclonal Antibodies Research (5 papers)HER2/EGFR in Cancer Research (4 papers)Receptor Mechanisms and Signaling (3 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Oncology Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Molecular Cell
Partner nations: United States France Japan

In The Last Decade

Elizabeth Luis

18 papers receiving 854 citations

Peers

Countries citing papers authored by Elizabeth Luis

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Luis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Luis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Luis more than expected).

Fields of papers citing papers by Elizabeth Luis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Luis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Luis. The network helps show where Elizabeth Luis may publish in the future.

Co-authorship network of co-authors of Elizabeth Luis

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Luis. A scholar is included among the top collaborators of Elizabeth Luis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Luis. Elizabeth Luis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies 2015 ·Clinical Cancer Research ·Jyoti Asundi,Lisa Crocker,Jarrod R. Tremayne,Peter S. Chang,Chie Sakanaka,(unknown),Susan D. Spencer,Sreedevi Chalasani,Elizabeth Luis,Karen E. Gascoigne,Rupal Desai,Rajiv Raja,Brad A. Friedman,Peter M. Haverty,Paul Polakis,Ron Firestein	28
2	An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models 2014 ·Molecular Cancer Therapeutics ·Suzie J. Scales,Nidhi Gupta,Glenn Pacheco,Ron Firestein,Dorothy French,Hartmut Koeppen,Linda Rangell,Vivian Barry-Hamilton,Elizabeth Luis,Josefa Chuh,Yin Zhang,Gladys S. Ingle,Aimee Fourie-O’Donohue,Katherine R. Kozak,Sarajane Ross,Mark S. Dennis,Susan D. Spencer	52
3	E-Cadherin Couples Death Receptors to the Cytoskeleton to Regulate Apoptosis 2014 ·Molecular Cell ·Min Lu,Scot A. Marsters,Xiaofen Ye,Elizabeth Luis,Lino C. Gonzalez,Avi Ashkenazi	86
4	Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor 2014 ·PLoS ONE ·Patrick C. G. Haddick,Irene Tom,Elizabeth Luis,Gabriel Quiñones,Bernd J. Wranik,Sree R. Ramani,Jean-Philippe Stéphan,Marc Tessier‐Lavigne,Lino C. Gonzalez	40
5	Abstract 4494: A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers 2014 ·Cancer Research ·Suzie J. Scales,Nidhi Gupta,Glenn Pacheco,Ron Firestein,Dorothy French,Josefa Chuh,Yin Zhang,Leanne Berry,Jenny Boström,Elizabeth Luis,(unknown),Katherine R. Kozak,Sarajane Ross,Mark S. Dennis,Jay Tibbitts,Susan D. Spencer	1
6	Abstract 4502: Nonclinical characterization and tolerability of a surrogate anti-mesothelin-MMAE antibody-drug conjugate 2014 ·Cancer Research ·Nidhi Gupta,Willy A. Solis,Reina N. Fuji,(unknown),Glenn Pacheco,Elizabeth Luis,Josefa Chuh,Dorothy French,(unknown),Mark S. Dennis,Katherine R. Kozak,Sarajane Ross,Jay Tibbitts,Susan D. Spencer,Suzie J. Scales	1
7	Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele 2013 ·PLoS ONE ·Steven E. Kauder,Lydia Santell,Elaine Mai,(unknown),Elizabeth Luis,(unknown),Jeff Lutman,Navneet Ratti,(unknown),Henry R. Maun,Eric Stefanich,Lino C. Gonzalez,Robert Graham,Lauri Diehl,William A. Faubion,Mary Keir,Judy Young,Amitabha Chaudhuri,Robert A. Lazarus,Jackson G. Egen	17
8	Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor 2013 ·Journal of Biological Chemistry ·Susmith Mukund,(unknown),Holly J. Clarke,Azadeh Madjidi,Jacob E. Corn,Lance Kates,Ganesh Kolumam,Vicky Chiang,Elizabeth Luis,Jeremy Murray,Yingnan Zhang,Isidro Hötzel,Christopher M. Koth,Bernard B. Allan	33
9	Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators 2012 ·PLoS ONE ·Justin M. Scheer,Wendy Sandoval,J. Michael Elliott,Lily Shao,Elizabeth Luis,Sock-Cheng Lewin-Koh,Gabriele Schaefer,Richard Vandlen	32
10	Molecular basis for negative regulation of the glucagon receptor 2012 ·Proceedings of the National Academy of Sciences ·Christopher M. Koth,Jeremy Murray,Susmith Mukund,Azadeh Madjidi,Alexandra H. Minn,Holly J. Clarke,(unknown),(unknown),Elizabeth Luis,Alberto Estevez,(unknown),Yingnan Zhang,Isidro Hötzel,Bernard B. Allan	103
11	An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma 2011 ·Clinical Cancer Research ·Jyoti Asundi,Chae Reed,(unknown),Krista McCutcheon,Ronald E. Ferrando,Suzanna Clark,Elizabeth Luis,Janet Tien,Ron Firestein,Paul Polakis	44
12	Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1 2011 ·Journal of Biological Chemistry ·Adrian A. Lobito,Sree R. Ramani,Irene Tom,J. Fernando Bazán,Elizabeth Luis,Wayne J. Fairbrother,Wenjun Ouyang,Lino C. Gonzalez	35
13	Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET 2010 ·Nuclear Medicine and Biology ·Jeff N. Tinianow,Herman Gill,Annie Ogasawara,Judith E. Flores,Alexander Vanderbilt,Elizabeth Luis,Richard Vandlen,Martine Darwish,Jagath R. Junutula,(unknown),Jan Mařı́k	90
14	Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer 2009 ·Molecular Cancer Therapeutics ·Jiping Zha,Carol O’Brien,Heidi Savage,Ling‐Yuh Huw,Fiona Zhong,Leanne Berry,Gail D. Lewis Phillips,Elizabeth Luis,Guy Cavet,Xiaolan Hu,Lukas C. Amler,Mark R. Lackner	66
15	Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models 2007 ·Cancer Research ·Youjun Chen,Suzanna Clark,Terence Z. Wong,Yongmei Chen,Yvonne Chen,Mark S. Dennis,Elizabeth Luis,Fiona Zhong,Sheila Bheddah,Hartmut Koeppen,Alvin Gogineni,Sarajane Ross,Paul Polakis,William Mallet	70
16	EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer 2004 ·Cancer Research ·Weiguang Mao,Elizabeth Luis,Sarajane Ross,(unknown),Christine Tan,Craig Crowley,(unknown),(unknown),Peter D. Senter,Hartmut Koeppen,Paul Polakis	105
17	Selective Detection of Membrane Proteins Without Antibodies 2002 ·Molecular & Cellular Proteomics ·David Arnott,(unknown),Elizabeth Luis,(unknown),James C. Marsters,John T. Stults	71
18	Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro 1996 ·Endocrine ·Kathleen L. King,(unknown),Jane Winer,Elizabeth Luis,(unknown),Jeff Hooley,Paul Williams,Jennie P. Mather	11

About Elizabeth Luis

Elizabeth Luis is a scholar working on Biotechnology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 885 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (271 citations), Oncology (275 citations) and Cellular and Molecular Neuroscience (160 citations). Elizabeth Luis has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Lino C. Gonzalez, Paul Polakis, Hartmut Koeppen, Sarajane Ross, Min Lu, Avi Ashkenazi, Xiaofen Ye, Scot A. Marsters, James C. Marsters and John T. Stults. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact